Nguyen, Q. T., Lee, E. J., Huang, M. G., Park, Y. I., Khullar, A., & Plodkowski, R. A. (2015). Diagnosis and treatment of patients with thyroid cancer. American Health & Drug Benefits, 8(1), 30–40.
Google Scholar
La Vecchia, C., Malvezzi, M., Bosetti, C., Garavello, W., Bertuccio, P., Levi, F., et al. (2015). Thyroid cancer mortality and incidence: a global overview. International Journal of Cancer, 136(9), 2187–2195. https://doi.org/10.1002/ijc.29251
CAS
Article
PubMed
Google Scholar
Cancer Research UK Thyroid cancer incidence statistics. www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/thyroid-cancer/incidence. Accessed 1st December 2019.
Smittenaar, C. R., Petersen, K. A., Stewart, K., & Moitt, N. (2016). Cancer incidence and mortality projections in the UK until 2035. British Journal of Cancer, 115(9), 1147–1155. https://doi.org/10.1038/bjc.2016.304
CAS
Article
PubMed
PubMed Central
Google Scholar
Busaidy, N. L., & Cabanillas, M. E. (2012). Differentiated thyroid cancer: Management of patients with radioiodine nonresponsive disease. Journal of Thyroid Research, 2012, 618985.
PubMed
PubMed Central
Google Scholar
Department of Health NHS conditions: thyroid cancer. https://www.nhs.uk/conditions/thyroid-cancer/. Accessed June 2020.
Cancer Research UK Thyroid cancer treatment. https://www.cancerresearchuk.org/about-cancer/thyroid-cancer/treatment. Accessed 30th November 2019.
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard Ba, G., et al. (2014). Guidelines for the management of thyroid cancer, third edition. Clinical Endocrinology, 81, 1–122.
CAS
PubMed
Google Scholar
Mols, F., Schoormans, D., Smit, J. W. A., Netea-Maier, R. T., Links, T. P., van der Graaf, W. T. A., et al. (2018). Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: results from the PROFILES Registry. Head & Neck, 40(10), 2235–2245.
Google Scholar
National Institute for Health and Care Excellence (NICE) Guide to the methods of technology appraisal 2013. Process and methods [PMG9]. Published date: April 2013. https://nice.org.uk/process/pmg9. Accessed 29 Jan 2020.
Brazier, J., Ara, R., Azzabi, I., Busschbach, J., Chevrou-Séverac, H., Crawford, B., et al. (2019). Identification, review, and use of health state utilities in cost-effectiveness models: an ispor good practices for outcomes research task force report. Value in Health, 22(3), 267–275.
PubMed
Google Scholar
Prescient and Strategic Intelligence (2018). Thyroid cancer therapeutics—pipeline analysis 2018, clinical trials & results, patent, designation, collaboration, and other developments. https://www.psmarketresearch.com/market-analysis/thyroid-cancer-therapeutics-pipeline-analysis Accessed 30 November 2018.
CRD (2009). Systematic reviews: CRD's guidance for undertaking reviews in health care. https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf
Arber, M., Garcia, S., Veale, T., Edwards, M., Shaw, A., & Glanville, J. M. (2017). Performance of ovid medline search filters to identify health state utility studies. International Journal of Technology Assessment in Health Care, 33(4), 472–480. https://doi.org/10.1017/S0266462317000897
Article
PubMed
Google Scholar
Department of Health (2013). Guide to the methods of technology appraisal. In National Institute for Health and Care Excellence (Ed.). https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781
Ara, R., & Brazier, J. (2008). Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value in Health, 11(7), 1131–1143.
PubMed
Google Scholar
Crott, R., & Briggs, A. (2010). Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. European Journal of Health Econonomics, 11(4), 427–434.
Google Scholar
Hedman, C., Djarv, T., Strang, P., & Lundgren, C. I. (2017). Effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma: a population-based study in Sweden. Thyroid, 27(8), 1034–1042.
CAS
PubMed
Google Scholar
Rogers, S. N., Mepani, V., Jackson, S., & Lowe, D. (2017). Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. British Journal of Oral and Maxillofacial Surgery, 55(7), 666–673.
CAS
PubMed
Google Scholar
Gou, J., Cheng, W., Lei, J., Pan, Q., You, W., Cai, M., et al. (2017). Health-related quality-of-life assessment in surgical patients with papillary thyroid carcinoma: a single-center analysis from Mainland China. Medicine, 96(38), e8070.
PubMed
PubMed Central
Google Scholar
Botella-Carretero, J. I., Galan, J. M., Caballero, C., Sancho, J., & Escobar-Morreale, H. F. (2003). Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocrine-Related Cancer, 10(4), 601–610.
CAS
PubMed
Google Scholar
Crevenna, R., Zettinig, G., Keilani, M., Posch, M., Schmidinger, M., Pirich, C., et al. (2003). Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Supportive Care in Cancer, 11(9), 597–603.
PubMed
Google Scholar
Gamper, E. M., Wintner, L. M., Rodrigues, M., Buxbaum, S., Nilica, B., Singer, S., et al. (2015). Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme. European Journal of Nuclear Medicine & Molecular Imaging, 42(8), 1179–1188.
CAS
Google Scholar
Hedman, C., Djarv, T., Strang, P., & Lundgren, C. I. (2015). Thyroid symptoms effect on general long-term quality of life among patients with differentiated thyroid carcinoma-a population based cohort study in Sweden. Thyroid, 25, A280.
Google Scholar
Hedman, C., Djarv, T., Strang, P., & Lundgren, C. I. (2016). Determinants of long-term quality of life in patients with differentiated thyroid carcinoma—a population-based cohort study in Sweden. Acta Oncologica, 55(3), 365–369.
PubMed
Google Scholar
Huang, J. K., Ma, L., Song, W. H., Lu, B. Y., Huang, Y. B., & Dong, H. M. (2016). Quality of life and cosmetic result of single-port access endoscopic thyroidectomy via axillary approach in patients with papillary thyroid carcinoma. OncoTargets and Therapy, 9, 4053–4059.
PubMed
PubMed Central
Google Scholar
Lee, M. C., Park, H., Lee, B. C., Lee, G. H., & Choi, I. J. (2016). Comparison of quality of life between open and endoscopic thyroidectomy for papillary thyroid cancer. Head & Neck, 38(Suppl 1), E827-831.
Google Scholar
Pacini, F., Ladenson, P. W., Schlumberger, M., Driedger, A., Luster, M., Kloos, R. T., et al. (2006). Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. Journal of Clinical Endocrinology & Metabolism, 91(3), 926–932.
CAS
Google Scholar
Ratki, S. K. R., Fallahi, B., Saghari, M., Ardekani, A. E., Beiki, D., Mirabzade, A., et al. (2012). Quality of life in patients with differentiated thyroid carcinoma treated by radioactive Iodine-131. Iranian Journal of Nuclear Medicine, 20, 136.
Google Scholar
Shah, M. D., Witterick, I. J., Eski, S. J., Pinto, R., & Freeman, J. L. (2006). Quality of life in patients undergoing thyroid surgery. Journal of Otolaryngology, 35(4), 209–215.
Google Scholar
Tagay, S., Herpertz, S., Langkafel, M., Erim, Y., Bockisch, A., Senf, W., et al. (2006). Health-related quality of life, depression and anxiety in thyroid cancer patients. Quality of Life Research, 15(4), 695–703.
PubMed
Google Scholar
Tagay, S., Herpertz, S., Langkafel, M., Erim, Y., Freudenberg, L., Schopper, N., et al. (2005). Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. European Journal of Endocrinology, 153(6), 755–763.
CAS
PubMed
Google Scholar
Tan, L. G., Nan, L., Thumboo, J., Sundram, F., & Tan, L. K. (2007). Health-related quality of life in thyroid cancer survivors. Laryngoscope, 117(3), 507–510.
PubMed
Google Scholar
Vigario Pdos, S., Chachamovitz, D. S., Teixeira Pde, F., Rocque Mde, L., Santos, M. L., & Vaisman, M. (2014). Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. Arquivos Brasileiros de Endocrinologia e Metabologia, 58(3), 274–281.
PubMed
Google Scholar
Economopoulos, K. P., Benitez, L., Gazelle, G., Halpern, E. F., Donelan, K., Swan, J., et al. (2014). Responsiveness of generic utilities indices for patients undergoing surgery for thyroid cancer. Thyroid, 24, A103.
Google Scholar
Esnaola, N. F., Cantor, S. B., Sherman, S. I., Lee, J. E., & Evans, D. B. (2001). Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery, 130(6), 921–930.
CAS
PubMed
Google Scholar
Kebebew, E., Duh, Q. Y., & Clark, O. H. (2000). Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. World Journal of Surgery, 24(11), 1295–1302.
CAS
PubMed
Google Scholar
Lubitz, C. C., De Gregorio, L., Fingeret, A. L., Economopoulos, K. P., Termezawi, D., Hassan, M., et al. (2017). Measurement and variation in estimation of quality of life effects of patients undergoing treatment for papillary thyroid carcinoma. Thyroid, 27(2), 197–206.
CAS
PubMed
PubMed Central
Google Scholar
Husson, O., Haak, H. R., Buffart, L. M., Nieuwlaat, W. A., Oranje, W. A., Mols, F., et al. (2013). Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncologica, 52(2), 249–258.
PubMed
Google Scholar
Kung, S., Rummans, T. A., Colligan, R. C., Clark, M. M., Sloan, J. A., Novotny, P. J., et al. (2006). Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clinic Proceedings, 81(12), 1545–1552.
PubMed
Google Scholar
Roberts, K. J., Lepore, S. J., & Urken, M. L. (2008). Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. Journal of Cancer Education, 23(3), 186–191.
PubMed
Google Scholar
Schroeder, P. R., Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Sherman, S. I., et al. (2006). A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. Journal of Clinical Endocrinology & Metabolism, 91(3), 878–884.
CAS
Google Scholar
Singer, S., Lincke, T., Gamper, E., Bhaskaran, K., Schreiber, S., Hinz, A., et al. (2012). Quality of life in patients with thyroid cancer compared with the general population. Thyroid, 22(2), 117–124.
PubMed
Google Scholar
Borget, I., Bonastre, J., Catargi, B., Deandreis, D., Zerdoud, S., Rusu, D., et al. (2015). Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer: results from the randomized phase III ESTIMABL trial. Journal of Clinical Oncology, 33(26), 2885–2892.
CAS
PubMed
Google Scholar
NHS Scotland (2015). Cabozantinib SMC No. (1022/15). In Scottish Medicines Consortium (Ed.).
Fordham, B. A., Kerr, C., de Freitas, H. M., Lloyd, A. J., Johnston, K., Pelletier, C. L., et al. (2015). Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer. Patient Preference & Adherence, 9, 1561–1572.
Google Scholar
Kerr, C., Fordham, B., de Freitas, H. M., Pelletier, C. L., & Lloyd, A. (2014). Health state utility valuation in radio-iodine refractory differentiated thyroid cancer (RR-DTC). Value in Health, 17(7), A646.
CAS
PubMed
Google Scholar
Schlumberger, M., Jarzab, B., Elisei, R., Siena, S., Bastholt, L., De La Fouchardiere, C., et al. (2013). Phase III randomized, double-blinded, placebocontrolled trial of sorafenib in locally advanced or metastatic patients with radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC)-exploratory analyses of patient-reported outcomes. Thyroid, 23, A49–A50.
Google Scholar
Tremblay, G., Lloyd, A., Majethia, U., Pelletier, C., Forsythe, A., & Briggs, A. (2015). Incremental quality adjusted life years (QALY) analysis in absence of head to head and health related quality of life (hrqol) data: a case study in thyroid cancer. Value in Health, 18(7), A707.
Google Scholar
NHS Scotland (2015). Sorafenib SMC No.(1055/15). In Scottish Medicines Consortium (Ed.).
McIntyre, C., Jacques, T., Palazzo, F., Farnell, K., & Tolley, N. (2018). Quality of life in differentiated thyroid cancer. International Journal of Surgery, 50, 133–136.
PubMed
Google Scholar
Wang, T., Jiang, M., Ren, Y., Liu, Q., Zhao, G., Cao, C., et al. (2018). Health-related quality of life of community thyroid cancer survivors in Hangzhou. China. Thyroid, 28(8), 1013–1023.
CAS
PubMed
Google Scholar
Ryu, M., & Hwang, J. I. (2019). Cancer site differences in the health-related quality of life of Korean cancer survivors: results from a Population-based Survey. Public Health Nursing, 36(2), 144–154.
PubMed
Google Scholar
Hedman, C., Djarv, T., Strang, P., & Lundgren, C. I. (2018). Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a Prospective Swedish Population-Based Study. Thyroid, 26, 26.
Google Scholar
Haraj, N. E., Bouri, H., El Aziz, S., Nani, S., Habti, N., & Chadli, A. (2019). Evaluation of the quality of life in patients followed for differentiated cancer of the thyroid. Annales d Endocrinologie, 80(1), 26–31.
PubMed
Google Scholar
Blamey, S., Barraclough, B., Delbridge, L., Mernagh, P., Standfield, L., & Weston, A. (2005). Using recombinant human thyroid-stimulating hormone for the diagnosis of recurrent thyroid cancer. Australia and New Zealand Journal of Surgery, 75, 10–20.
Google Scholar
Haugen, B., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P., Sherman, S., et al. (1999). A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. The Journal of Clinical Endocrinology & Metabolism, 84(11), 3877–3885.
CAS
Google Scholar
Brose, M. S., Nutting, C. M., Jarzab, B., Elisei, R., Siena, S., Bastholt, L., et al. (2014). Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet, 384(9940), 319–328.
CAS
PubMed
PubMed Central
Google Scholar
Janssen, B., & Szende, A. (2014). Population Norms for the EQ-5D. In A. Szende, B. Janssen, & J. Cabases (Eds.), Self-reported population health: an international perspective based on EQ-5D (pp. 19–30). Dordrecht: Springer, Netherlands.
Google Scholar
Ara, R., Brazier, J., Peasgood, T., & Paisley, S. (2017). The identification, review and synthesis of health state utility values from the literature. Pharmacoeconomics, 35(1), 43–55. https://doi.org/10.1007/s40273-017-0547-8
Article
PubMed
Google Scholar
Weinstein, M. C., O’Brien, B., Hornberger, J., Jackson, J., Johannesson, M., McCabe, C., et al. (2003). Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value in Health, 6(1), 9–17.
PubMed
Google Scholar
Brazier, J., Green, C., & A Kanis, J. (2002). A systematic review of health state utility values for osteoporosis-related conditions (Vol. 13).
Tonmukayakul, U., Le, L.K.-D., Mudiyanselage, S. B., Engel, L., Bucholc, J., Mulhern, B., et al. (2018). A systematic review of utility values in children with cerebral palsy. Quality of Life Research, 28, 1–12.
PubMed
Google Scholar
Forsythe, A., Brandt, P. S., Dolph, M., Patel, S., Rabe, A., & Tremblay, G. (2018). Systematic review of health state utility values for acute myeloid leukemia. ClinicoEconomics and Outcomes Research, 10, 83.
PubMed
Google Scholar